image
DiaMedica Therapeutics Inc. DMAC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.76
5.32 %
$ 161 M
Market Cap
-5.87
P/E
Price Target Average
123.40%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
20.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets DiaMedica Therapeutics Inc.
image
Wall Street analysts predict an average 1-year price target for DMAC of $8.4 , with forecasts ranging from a low of $7 to a high of $10 .
DMAC Lowest Price Target Wall Street Target
7 USD 86.17%
DMAC Average Price Target Wall Street Target
8.4 USD 123.40%
DMAC Highest Price Target Wall Street Target
10 USD 165.96%
Price
Max Price Target
Min Price Target
Average Price Target
101099887766554433Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart DMAC

image
$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0201520152018201820232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart DMAC

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)201520152018201820232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart DMAC

image
$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)201520152018201820232023202420242025202520262026202720272028202820292029